143 related articles for article (PubMed ID: 12174003)
1. Comparative immunogenicity of hepatitis B vaccine administered into the ventrogluteal area and anterolateral thigh in infants.
Cook IF; Murtagh J
J Paediatr Child Health; 2002 Aug; 38(4):393-6. PubMed ID: 12174003
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccine in infants: a randomized controlled trial comparing gluteal versus anterolateral thigh muscle administration.
Alves AS; Nascimento CM; Granato CH; Sato HK; Morgato MF; Pannuti CS
Rev Inst Med Trop Sao Paulo; 2001; 43(3):139-43. PubMed ID: 11452321
[TBL] [Abstract][Full Text] [Related]
3. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders.
Das K; Gupta RK; Kumar V; Kar P
World J Gastroenterol; 2003 May; 9(5):1132-4. PubMed ID: 12717874
[TBL] [Abstract][Full Text] [Related]
5. Ventrogluteal area--a suitable site for intramuscular vaccination of infants and toddlers.
Cook IF; Murtagh J
Vaccine; 2006 Mar; 24(13):2403-8. PubMed ID: 16406175
[TBL] [Abstract][Full Text] [Related]
6. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B vaccination in preterm infants.
Gołebiowska M; Kardas-Sobantka D; Chlebna-Sokół D; Sabanty W
Eur J Pediatr; 1999 Apr; 158(4):293-7. PubMed ID: 10206126
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children.
Leonardi S; Praticò AD; Lionetti E; Spina M; Vitaliti G; La Rosa M
World J Gastroenterol; 2012 Oct; 18(40):5729-33. PubMed ID: 23155313
[TBL] [Abstract][Full Text] [Related]
10. Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.
Kaech C; Pache I; Bürgisser P; Elzi L; Darling KE; Cavassini M
J Infect; 2012 Aug; 65(2):157-64. PubMed ID: 22410383
[TBL] [Abstract][Full Text] [Related]
11. Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: a comparison of immunogenicity in infants and preschool children.
Egemen A; Aksit S; Kurugöl Z; Erensoy S; Bilgiç A; Akilli M
Vaccine; 1998 Oct; 16(16):1511-5. PubMed ID: 9711797
[TBL] [Abstract][Full Text] [Related]
12. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of low dose intradermal hepatitis B vaccine and its comparison with standard dose intramuscular vaccination.
Gomber S; Sharma R; Ramachandran VG
Indian Pediatr; 2004 Sep; 41(9):922-6. PubMed ID: 15475635
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy infants.
Vesikari T; Martin JC; Liss CL; Liska V; Schödel FP; Bhuyan PK
Pediatr Infect Dis J; 2011 Jul; 30(7):e109-13. PubMed ID: 21552183
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
[TBL] [Abstract][Full Text] [Related]
16. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation.
Fabrizi F; Andrulli S; Bacchini G; Corti M; Locatelli F
Nephrol Dial Transplant; 1997 Jun; 12(6):1204-11. PubMed ID: 9198052
[TBL] [Abstract][Full Text] [Related]
17. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.
Duval B; Gîlca V; Boulianne N; De Wals P; Massé R; Trudeau G; De Serres G
Pediatr Infect Dis J; 2005 Mar; 24(3):213-8. PubMed ID: 15750456
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of hepatitis B vaccine administered into ventrogluteal vs. anterolateral thigh sites in infants: a randomised controlled trial.
Junqueira AL; Tavares VR; Martins RM; Frauzino KV; da Costa e Silva AM; Minamisava R; Teles SA
Int J Nurs Stud; 2010 Sep; 47(9):1074-9. PubMed ID: 20189173
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial of hepatitis B vaccine in a simplified immunization programme.
Coursaget P; Yvonnet B; Sarr M; Vincelot P; Tortey E; Mboup S; Chiron JP; Diop-Mar I
Bull World Health Organ; 1986; 64(6):867-71. PubMed ID: 2951032
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
Young MD; Gooch WM; Zuckerman AJ; Du W; Dickson B; Maddrey WC
J Med Virol; 2001 Jul; 64(3):290-8. PubMed ID: 11424117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
